Etid klinik pou BPCO nan Maryland
15 etid pou BPCO ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
Ap rekriteFaz 4
Laj 40 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Baltimore
- Research Site, Baltimore
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Johns Hopkins University, Baltimore
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Baltimore
- Research Site, Columbia
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Baltimore
- Research Site, Potomac
- Research Site, Rosedale
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Oxon Hill
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT06283966STRIVE Post-Market Registry Study
- University of Maryland, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Maryland, Baltimore
- Johns Hopkins, Baltimore
- Tidal Health, Salisbury
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06376994SPIROMICS Study of Early COPD Progression (SOURCE)
- Johns Hopkins Bayview Medical Center, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Rockville
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT06961214OMEGA - Dietary Intervention - COPD Trial
- Johns Hopkins Bayview Campus, Baltimore
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT05297279Trial to Determine Effective Aspirin Dose in COPD
- Johns Hopkins Bayview Medical Center, Baltimore
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Mar 16, 2026 · NCT05265299Effectiveness of the WearME System for COPD Severity and Respiratory Function
- Johns Hopkins, Baltimore
- TidalHealth, Salisbury
Ap rekriteEtid obsèvasyon
Laj 21 a 100 · Tout sèks · Mizajou Sep 9, 2025 · NCT06751537Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Ascension St. Agnes Hospital, Baltimore
Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Maryland - Baltimore, Baltimore
Ap rekrite
Laj 30 ak plis · Tout sèks · Mizajou Feb 6, 2025 · NCT05204888Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.